![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...
DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.11 | -0.934579439252 | 11.77 | 12.197 | 10.52 | 50344 | 11.32309243 | CS |
4 | -0.34 | -2.83333333333 | 12 | 12.72 | 10.52 | 40330 | 11.68294326 | CS |
12 | 0.49 | 4.38675022381 | 11.17 | 14.99 | 10.3 | 52929 | 12.15538554 | CS |
26 | 5.75 | 97.2927241963 | 5.91 | 14.99 | 5.5 | 93322 | 9.90315356 | CS |
52 | -1.34 | -10.3076923077 | 13 | 14.99 | 5.05 | 91248 | 9.35975322 | CS |
156 | -6.94 | -37.311827957 | 18.6 | 30.43 | 5.05 | 83563 | 13.50445822 | CS |
260 | -10.34 | -47 | 22 | 30.43 | 5.05 | 85533 | 13.79728734 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions